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A multi-ethnic meta-analysis 
confirms the association of 
rs6570507 with adolescent 
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Adolescent idiopathic scoliosis (AIS) is the most common type of spinal deformity and has a significant 
genetic background. Genome-wide association studies (GWASs) identified several susceptibility loci 
associated with AIS. Among them is a locus on chromosome 6q24.1 that we identified by a GWAS 
in a Japanese cohort. The locus is represented by rs6570507 located within GPR126. To ensure the 
association of rs6570507 with AIS, we conducted a meta-analysis using eight cohorts from East Asia, 
Northern Europe and USA. The analysis included a total of 6,873 cases and 38,916 controls and yielded 
significant association (combined P = 2.95 × 10−20; odds ratio = 1.22), providing convincing evidence 
of the worldwide association between rs6570507 and AIS susceptibility. In silico analyses strongly 
suggested that GPR126 is a susceptibility gene at this locus.
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Adolescent idiopathic scoliosis (AIS) is defined as a lateral spinal curvature that occurs without obvious cause 
between age 10 and skeletal maturity. The prevalence of AIS in the adolescent population is approximately 2–3%1 
and AIS occurs predominantly in females2,3. AIS has been regarded as a multifactorial disease and a number 
of population, family and twin studies strongly suggest the importance of genetic factors in its etiology and 
pathogenesis4–7.
Genome-wide association study (GWAS) is a powerful tool to detect genetic variants associated with common 
diseases. Recently, several GWASs have identified several loci associated with AIS such as chromosome 10q24.31, 
6q24.1, 20p11.22, and 1p36.32 loci8–11. Our initial GWAS identified rs11190870, a common variant on chromo-
some 10q24.31 that showed significant association with AIS in a Japanese cohort8 and subsequent multi-ethnic 
meta-analysis provided convincing evidence of the association12. In addition, recent validation studies in different 
populations have also reported its significant associations13–15. Thus, the association of the 10q24.31 locus with 
AIS has been confirmed in multiple studies; however, other AIS loci have not been fully investigated.
In our previous GWAS, we identified an additional genetic variant, rs6570507 on chromosome 6q24.1, asso-
ciated with AIS in a Japanese cohort16. The association was replicated in independent cohorts of Chinese and 
Caucasian in the USA16; however, additional studies would be necessary to confirm the association and to identify 
the susceptibility gene at the locus.
In this study, we performed a meta-analysis using multi-ethnic cohorts of ~46,000 subjects. The result pro-
vided convincing evidence of the association of rs6570507 with AIS susceptibility, suggesting that the chro-
mosome 6q24.1 locus is related to the global risk of AIS. In silico analyses strongly suggested that GPR126 is a 
susceptibility gene at this locus.
Results
Association of rs6570507 and AIS susceptibility. We conducted the meta-analysis of rs6570507 using 
eight cohorts (Table 1, Fig. 1). Three cohorts were previously reported16, and the other five were recruited for this 
study that included cohorts from Guangzhou (case 647 and control 1,048), Hong Kong (case 300 and control 
788), Beijing (case 482 and control 861), USA (case 1,360 and control 7,267), and Scandinavia (case 1,522 and 
control 1,804). Finally, 6,873 cases and 38,916 controls were included in the meta-analysis. The analysis showed 
a convincing association between rs6570507 and AIS: combined P = 2.95 × 10−20; odds ratio (OR) = 1.22; 95% 
confidence interval (CI) = 1.17–1.27 (Table 1, Supplementary Fig. S1). ORs were >1 in all eight cohorts, with 
little difference between ethnic groups. The analysis did not show any significant heterogeneity, suggesting no 
statistical difference between studies. Because AIS has clinical evidence of sexual dimorphism17, we performed 
gender-stratified analyses to determine whether a genetic difference existed between males and females (Table 2, 
Supplementary Fig. S1). However, no gender difference was observed in the association.
Fine mapping. The sentinel SNP rs6570507 is present in an intron of GPR126 (encoding G protein-coupled 
receptor 126), and GPR126 is the only gene contained within the linkage disequilibrium (LD) block (r2 > 0.8) rep-
resented by rs6570507 (ref.16). To identify the candidate susceptibility gene in the locus, we evaluated the topolog-
ically associated domains (TADs) around the associated SNPs. Hi-C data18 (http://promoter.bx.psu.edu/hi-c/view.
php) revealed that GPR126 and VTA1 (encoding vesicle trafficking 1) were included in the TAD that contained 
the LD block (Fig. 2). Using expression quantitative trait loci (eQTL) data from the Genotype-Tissue Expression 
(GTEx) project19, we investigated the target genes regulated by rs6570507. We found that the expression level of 
GPR126 in subcutaneous adipose tissue and sun-exposed skin was significantly associated with rs6570507 and 
its risk allele rs6570507-A decreased the expression (Supplementary Fig. S2). These data strongly suggested that 
GPR126 is the most plausible AIS susceptibility gene at this locus.
Population Study
Sample number RAF
P value* OR (95% CI) PhetCase Control Case Control
Japanese
Japan 1 1033 1473 0.49 0.42 1.37 × 10−6 1.32 (1.18–1.48)
Japan 2 786 24466 0.48 0.43 3.02 × 10−5 1.24 (1.12–1.37)
Japanese Combined 1819 25939 2.15 × 10−10 1.28 (1.18–1.38) 0.40
Chinese
Nanjing 743 1209 0.39 0.35 3.36 × 10−3 1.22 (1.06–1.39)
Guangzhou 647 1048 0.41 0.37 2.19 × 10−2 1.18 (1.02–1.36)
Hong Kong 300 788 0.40 0.38 4.79 × 10−1 1.07 (0.88–1.30)
Beijing 482 861 0.37 0.34 8.93 × 10−2 1.15 (0.98–1.36)
Chinese Combined 2172 3906 7.79 × 10−5 1.17 (1.08–1.26) 0.75
East Asian combined 3991 29845 2.85 × 10−13 1.22 (1.16–1.29) 0.47
Caucasian
USA 1360 7267 0.34 0.30 7.95 × 10−6 1.22 (1.12–1.33)
Scandinavia 1522 1804 0.32 0.28 6.63 × 10−4 1.20 (1.08–1.34)
Caucasian Combined 2882 9071 1.76 × 10−8 1.21 (1.13–1.30) 0.85
All combined 6873 38916 2.95 × 10−20 1.22 (1.17–1.27) 0.71
Table 1. Association of rs6570507 with adolescent idiopathic scoliosis. RAF, risk allele (rs6570507-A) 
frequency; OR, odds ratio; CI, confidence interval; Phet, P-value for Cochran’s Q-test for heterogeneity. *The 
p-values were calculated from the Cochran-Armitage trend test for each stage and combined p-values were 
calculated by the inverse variance method.
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Target sequencing. Recently, numerous sequencing studies of candidate genes in GWAS loci identified rare 
large-effect variants20–22. To assess the potential contribution of rare variants at the chromosome 6q24.1 locus to 
AIS, we carried out targeted sequencing. We screened the coding regions and exon-intron boundaries of VTA1 
(chr.6: 142468421–142539785) and GPR126 (chr.6: 142623463–142764657) across 10,121 individuals (2,721 cases 
and 7,400 controls). The coverage rate of the target region, presented as an average in all individuals covered with 
≥20 reads at each position, was 99.96%. We identified 183 single nucleotide variant (SNVs), 2 insertions and 9 
deletions. The single-variant association analysis for each nonsynonymous variant (including missense, splice 
site, nonsense, and frameshift variants) with MAF <0.05 demonstrated no rare variant with significant associa-
tions (Supplementary Table S1). Subsequently, we performed the gene-based association analyses by the cohort 
allelic sums test (CAST)23 and the sequence kernel association test (SKAT)24, using the nonsynonymous variants. 
Only GPR126 showed a nominal significant association (P = 4.65 × 10−2) with AIS by CAST; however, it did not 
reach the threshold for significance after Bonferroni correction (Supplementary Table S2).
Discussion
In our previous study, we identified the significant association between rs6570507 and AIS in Japanese and the 
association is replicated in the independent cohorts of Chinese and Caucasian in the USA. However, as the num-
bers of Chinese and Caucasian subjects were both limited, the association between rs6570507 and AIS in these 
populations does not provide convincing evidence. In the current study, we have conducted a meta-analysis using 
eight independent multi-ethnic-cohorts and showed significant and consistent association of rs6570507 with 
AIS across the different ethnic groups. Recently, evidence for association of rs6570507 with AIS was reported 
in a Chinese cohort of Zhejiang25; however, we did not use the data for our meta-analysis because the allele fre-
quency of rs6570507 in the control group of the study was quite different from the frequency for the Chinese in 
the public database (for example, the 1000 Genomes Project) and the minor allele was opposite. Nevertheless, our 
meta-analysis demonstrates convincing association between rs6570507 and AIS susceptibility.
For some common complex diseases, rare large-effect variants have recently been identified by targeted exon 
sequencing of genes within GWAS associated loci26,27. This approach is helpful to identify causal genes and to 
explain a further portion of disease variance. In the present study, we assessed the contribution of rare variants 
in the candidate genes at the locus; however, we could not find any statistically significant association in individ-
ual variants. GPR126 showed a nominally significant association by a gene-based study. The frequency of rare 
and low-frequency nonsynonymous variants was increased in cases, suggesting that AIS is caused by functional 
impairment of the GPR126 gene. However, in the current study, the evidence for association did not surpass 
Bonferroni correction. This negative result may be due to the insufficient sample size in the present study and 
further larger studies are required to evaluate the effect of rare and low-frequency variants in GPR126.
To identify the susceptibility gene at the chromosome 6q24.1 locus, we evaluated the TADs around the asso-
ciated SNPs using the Hi-C database. The data showed that GPR126 and VTA1 were involved in the TAD that 
contained the LD block of the AIS associated SNPs. All SNPs strongly correlated with rs6570507 (r2 > 0.8) were 
present in the GPR126 gene region. The eQTL data indicated that these SNPs were significantly associated with 
the expression level of GPR126 in some tissues, such as subcutaneous adipose tissue and sun-exposed skin. It is 
well known that AIS patients are associated with low body weight and low body mass index (BMI)28,29, and are 
also reported to be significantly associated with lower body fat30. These observations suggest that GPR126 has a 
potential to affect AIS susceptibility through the adipose tissues. However, tissues used in GTEx project are lim-
ited, and the sample size is different by tissue. Therefore, it may fail to identify tissues contributing to the disease 
Figure 1. The flow diagram of the meta-analysis using eight cohorts. Three cohorts (Japanese GWAS, 
replication study and Nanjing study) were previously reported16, and the other five were recruited for this 
analysis.
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pathology. In order to more optimally determine the effect of the associated SNPs on scoliosis, eQTL analysis in 
AIS-related tissues such as intervertebral disc, cartilage and bone should be performed. Moreover, our previous 
experiments indicated that GPR126 is highly expressed in the cartilage of human and proliferating chondrocytes 
of the vertebral body in mouse embryo16. Recently, Karner et al. reported that the mice with a conditional deletion 
of Gpr126 in the cartilage displayed the clinical features of AIS including postembryonic onset of spine curva-
tures with rotation and absence of vertebral malformations at birth31. These lines of evidence strongly suggested 
that the GPR126 is a susceptibility gene for AIS and its loss of function is implicated in the pathogenesis of AIS. 
Further studies are necessary to identify the causal variant at the locus and clarify its functional impact on the 
function of GPR126.
Figure 2. The Hi-C interaction surrounding the AIS associated region on chromosome 6q24.1. Hi-C 
interaction in H1-mesenchymal stem cell was generated by using the Interactive Hi-C Data Browser. 
GPR126 and VTA1 lie within the topologically associated domain (black triangle) that contains the linkage 










CI) PhetCase Control Case Control Case Control Case Control
Japanese
Japan 1 1033 1473 0.47 0.43 1.37 × 10−6 1.32 (1.18–1.48) — — — —




Combined 1713 11145 3.85 × 10
−10 1.29 
(1.19–1.39) 0.50  — —
Chinese
Nanjing 637 711 0.39 0.35 3.69 × 10−2 1.18 (1.01–1.38) 104 498 0.38 0.33 1.54 × 10
−1 1.25 
(0.92–1.70)
Guangzhou 552 584 0.41 0.38 5.24 × 10−2 1.18 (0.99–1.39) 95 464 0.41 0.37 3.92 × 10
−1 1.15 
(0.84–1.58)




Combined 1437 1784 8.51 × 10
−3 1.15 




combined 3150 12929 5.42 × 10
−11 1.23 




USA 1159 4405 0.34 0.30 1.15 × 10−4 1.21 (1.10–1.33) 201 2862 0.34 0.29 6.65 × 10
−2 1.22 
(0.99–1.51)
Scandinavia 1315 1804 0.32 0.28 2.43 × 10−3 1.19 (1.06–1.32) — — — —
Caucasian 
Combined 2474 6209 9.12 × 10
−7 1.20 
(1.12–1.29) 0.79 — —
All 
combined 5624 19138 2.95 × 10
−16 1.22 
(1.16–1.28) 0.56 558 18917 8.65 × 10
−3 1.19 
(1.04–1.35) 0.95
Table 2. Association of rs6570507 with adolescent idiopathic scoliosis by gender. RAF, risk allele (rs6570507-A) 
frequency; OR, odds ratio; CI, confidence interval; Phet, P-value for Cochran’s Q-test for heterogeneity. *The 
p-values were calculated from the Cochran-Armitage trend test for each stage and combined p-values were 
calculated by the inverse variance method.
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Materials and Methods
Subjects and genotyping. Informed consent was obtained from all subjects participating in this study. 
This study was approved by the ethics committee of the RIKEN center for Integrative Medical Sciences and all 
experiments were performed in accordance with relevant guidelines and regulations. All AIS subjects met clinical 
criteria including scoliosis with Cobb angle of 10° or more on standing spinal postero-anterior (P-A) radiographs 
and excluding other non-idiopathic forms of scoliosis. The subjects in the Japanese and Nanjing-Chinese cohorts 
were recruited and genotyped as previously described16. The details of additional studies: i.e., Guangzhou, Hong 
Kong, Beijing, USA, and Scandinavia studies were described as below.
Guangzhou study. AIS subjects were recruited from the First Affiliated Hospital and Sun Yat-sen Memorial 
Hospital of Sun Yat-sen University. They provided detailed histories, accepted physical examinations, underwent 
standard up-standing P-A radiography of the whole spine, and other testing such as magnetic resonance imaging 
(MRI), computed tomography (CT) and nuclear scintigraphy, when necessary. All AIS subjects were diagnosed 
at ages 10–16 years. Control subjects were recruited from individuals who received scoliosis screening at middle 
and primary schools in Guangzhou and fracture patients selected from the participating hospitals. All subjects 
were confirmed for not having AIS by x-ray scans of the spine. Routine history and physical examinations were 
also conducted to exclude other relevant diseases. Genomic DNA was extracted from blood using DNA Blood 
Mini-kit (Tiangen Biotech, Beijing, China). Primer extension sequencing (SNaPshot) assay (Applied Biosystems, 
CA, USA) was used for genotyping and the results were analyzed by GeneMarker software (SoftGenetics LLC, PA, 
USA) at Beijing Genomics Institute (Shenzhen, China) and checked by visual inspection of I.K. and H.D.
Hong Kong study. AIS subjects were recruited from the Duchess of Kent Children’s Hospital in Hong Kong. 
The inclusion criteria were as previously described32. Control subjects were randomly selected from the subjects 
recruited for the Genetic Study of Degenerative Disc Disease project33. All were confirmed not to have AIS by 
MRI examination of the spine. Genomic DNA was extracted from peripheral blood lymphocytes using standard 
procedures. The PCR-based invader assay (Third Wave Technologies, WI, USA) was used for genotyping.
Beijing Study. AIS subjects were recruited from Peking Union Medical College Hospital. All subjects under-
went clinical and radiologic examination such as whole spine X-ray, CT and MRI by expert spinal surgeons. 
Control subjects were recruited from in-house control bank. Genomic DNA was extracted from peripheral blood 
using the QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany). The MassARRAY system (Sequenom; 
BioMiao Biological Technology, Beijing, China) was used for genotyping.
USA Study. AIS subjects were recruited at Texas Scottish Rite Hospital for Children as previously described10 
and genotyped using the Illumina HumanCoreExome Beadchip array. For controls, we utilized a single dataset 
of individuals downloaded from the dbGaP web site (http://www.ncbi.nlm.nih.gov/sites/entrez?db=gap) from 
Geisinger Health System-MyCode, eMERGE III Exome Chip Study under phs000957.v1.p1 (https://www.ncbi.
nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000957.v1.p1). The dbGaP controls were previously 
genotyped on the same microarray platform used for cases. Only subjects of self-reported Non-Hispanic White 
were included in the present study. Phenotypes of all controls were reviewed to exclude any with musculoskeletal 
or neurological disorders. We applied initial per sample quality control measures and excluded sex inconsisten-
cies and any with missing genotype rate per person more than 0.03. Remaining samples were merged using the 
default mode in PLINK.1.9 (ref.34). Duplicated or related individuals were removed as previously described35. We 
used principal component analysis (PCA)36 on the merged data projected onto HapMap3 samples to correct pos-
sible stratification37. After quality controls, 8,647 subjects (1,360 AIS subjects and 7,287 controls) were included 
for the current study. We applied initial per-SNPs quality control measures using PLINK including genotyping 
call-rate per marker (>95%), minor allele frequency (>0.01) and deviation from Hardy-Weinberg equilibrium 
(cutoff p-value = 10−4). We noted that the SNP success rate was 99.99% for the rs6570507 and there was no signif-
icant difference in the missingness rate between cases and controls after quality controls.
Scandinavia study. AIS subjects were recruited from six hospitals in Sweden and one in Denmark as 
described previously to the Scoliosis and Genetics in Scandinavia (ScoliGeneS) study15,38–40. Individuals with 
a history or clinical sign of a non-idiopathic scoliosis and with neural abnormalities in a MRI of the spine were 
excluded. All control subjects were females and recruited from the Osteoporosis Prospective Risk Assessment 
cohort and PEAK-25 cohort41,42. Dual-energy X-ray absorptiometry (DXA) scan was performed in both cohorts 
and subjects showing any sign of a curved spine on DXA were excluded. Genomic DNA was extracted from blood 
or saliva using the QIAamp 96 DNA Blood Kit and the Autopure LS system (Qiagen). iPLEX Gold chemistry and 
the MassARRAY system (Agena Bioscience, CA, USA) were used for genotyping. Genotype calls were checked by 
two persons individually using the MassARRAY Typer v4.0 Software (Agena Bioscience).
Statistical analysis. The association between rs6570507 and AIS in each study was evaluated by the 
Cochrane-Armitage trend test. Data from the eight studies were combined using the inverse-variance method 
assuming a fixed-effects model in the METAL software package (http://csg.sph.umich.edu//abecasis/Metal/)43. 
The heterogeneity among studies was tested using Cochran’s Q test based upon inverse variance weights using 
METAL.
Target sequencing. Cases were recruited from collaborating hospitals of Japan Scoliosis Clinical Research 
Group (JSCRG)8,9, and controls were recruited from the BioBank Japan project, the Osaka-Midosuji Rotary Club 
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and the PharmaSNP Consortium44,45. Multiplex PCR-based target sequencing was carried out as previously 
described45. Primers were designed using the Primer 3 software (ver. 2.3.4) to obtain 180–300 bp PCR products. 
We amplified 9,847 bp consisting of 47 genomic fractions using three multiplex-PCR products with dual bar-
codes for each individual. After purifying of each library using Agencourt AMPure XP (Beckman Coulter, CA, 
USA), the library was applied to the bioanalyzer (Agilent Technologies, CA, USA) to check the size distribution 
and quantified using the KAPA library quantification kit (Kapa Biosystems, MA, USA) on an ABI Prism 7700 
sequence detection system (Life Technologies, CA, USA). Sequencing was carried out using the HiSeq. 2500 
instrument (Illumina) with 2 × 150-bp paired-end reads and dual 8-bp barcode sequences. Sequence reads were 
aligned to the human reference sequence (hg19) by Burrows-Wheeler Aligner (ver. 0.7.9a) and then applied to the 
RealignerTargetCreator and IndelRealigner tools using GATK (ver. 3.2.2) for each bam file. The quality control 
was performed as previously described45. We selected variants that clearly showed three peaks corresponding to 
three genotypes and two peaks if they were considered rare variants by visual inspection.
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